Regulatory perspectives on predictive analytics for complaints and recalls Regulatory Perspectives on Predictive Analytics for Complaints and Recalls As the pharmaceutical and biotechnology industries continue to evolve, the integration of predictive quality analytics into existing quality systems has gained traction. Regulatory Affairs (RA) professionals are at the forefront of ensuring compliance with regulations such as 21 CFR in the US, EU regulations, and ICH guidelines. This article provides a comprehensive regulatory explainer manual detailing the implementation of predictive quality analytics in relation to Out-of-Specification (OOS) results, Out-of-Trend (OOT) results, complaints, and recalls. Context Predictive quality analytics leverages data analytics and…

Setting thresholds and alert rules for predictive OOS and OOT flags Setting thresholds and alert rules for predictive OOS and OOT flags Predictive quality analytics for Out of Specification (OOS) and Out of Trend (OOT) situations has gained significant traction in the pharmaceutical and biotechnology sectors. As regulatory environments evolve, the expectation for robust data analytics in ensuring product quality and compliance has intensified. This article serves as a comprehensive regulatory explainer manual focused on establishing effective thresholds and alert rules for predictive analytics, emphasizing compliance with regulatory bodies across the US, EU, and UK. Context In the context of…

Visualising predictive risk across products, sites and markets Visualising Predictive Risk Across Products, Sites and Markets Regulatory Affairs Context In the ever-evolving landscape of the pharmaceutical and biotech industries, maintaining product quality and ensuring regulatory compliance are paramount. Predictive quality analytics, particularly concerning Out of Specification (OOS) and Out of Trend (OOT) results, plays a crucial role in paving the way for enhanced decision-making processes across various quality systems. These analytics leverage advanced technologies such as machine learning to integrate and visualize quality-related data, which can vastly improve risk management. This article serves as a guide for regulatory professionals, particularly…

Linking Predictive Quality Analytics to CAPA and Risk Mitigation Plans Linking Predictive Quality Analytics to CAPA and Risk Mitigation Plans In the pharmaceutical and biotechnology industries, maintaining compliance with regulatory expectations is essential for successful product development and market entry. Predictive quality analytics plays a pivotal role in this context, particularly in relation to out-of-specification (OOS) results, out-of-trend (OOT) observations, complaints management, and recall risk mitigation. This article serves as a regulatory explainer manual for integrating predictive quality analytics within Corrective and Preventive Action (CAPA) systems and broader risk management plans, aligning with the regulatory frameworks of the US, UK,…

KPIs that show ROI from predictive quality analytics programs KPIs that show ROI from predictive quality analytics programs In the pharmaceutical and biotechnology sectors, maintaining high standards of quality assurance is paramount. The application of predictive quality analytics is becoming increasingly vital in ensuring compliance with regulatory requirements and enhancing operational efficiency. This article serves as a comprehensive guide for regulatory affairs professionals focusing on key performance indicators (KPIs) that quantify the return on investment from predictive quality analytics programs, specifically in managing out-of-specification (OOS) and out-of-trend (OOT) results, complaints, and recalls. Regulatory Affairs Context Regulatory Affairs (RA) professionals operate…